Trending...
- Dallas Maestro Jason Davis Sr. Celebrates Prayze Factor Award Victory Unveils Duo Album Release - 297
- California: Governor Newsom takes action to help lower prices amid Trump's nationwide gas and diesel price spike - 152
- California: Governor Newsom signs historic law to stop big business from shutting out competition, cuts red tape to speed up business permitting - 131
ANNAPOLIS, Md., Jan. 10, 2025 ~ In an exciting announcement, Alphyn, a clinical-stage dermatology company, revealed that their CEO Neal Koller will be presenting at several investor conferences during the upcoming J.P. Morgan Healthcare Week in San Francisco.
The first conference, Biotech Showcase, will take place on January 13th at 10:45 a.m. at the Hilton San Francisco Union Square. Mr. Koller will then move on to the Redefining Every Stage of Investment (RESI) JPM conference on January 14th at 11 a.m. at the San Francisco Marriott Marquis. He has been selected as a finalist in the RESI Innovators Pitch Challenge.
Later that same day, Mr. Koller will also be speaking at NEXUS 2025 from 3 p.m. to 9 p.m. at the Hanger in South San Francisco. During these presentations, he will provide an overview of Alphyn's corporate developments and discuss their lead product candidate, Zabalafin Hydrogel.
More on The Californer
Zabalafin Hydrogel is currently in development to treat atopic dermatitis (AD), a chronic skin condition that affects millions of people worldwide. It is set to begin Phase 2b clinical trials this year and has shown promising results in treating all aspects of AD - including bacterial causes and exacerbation of the disease, as well as managing symptoms such as itchiness, inflammation, and infection.
Alphyn's second candidate is aimed at treating epidermolysis bullosa, a group of rare and potentially fatal skin diseases. With these innovative Multi-Target Therapeutics®, Alphyn hopes to make significant advancements in the field of dermatology and improve the quality of life for those suffering from these conditions.
Investors and industry professionals alike are eagerly anticipating Mr. Koller's presentations and updates on Alphyn's groundbreaking clinical programs during J.P Morgan Healthcare Week next week in San Francisco.
The first conference, Biotech Showcase, will take place on January 13th at 10:45 a.m. at the Hilton San Francisco Union Square. Mr. Koller will then move on to the Redefining Every Stage of Investment (RESI) JPM conference on January 14th at 11 a.m. at the San Francisco Marriott Marquis. He has been selected as a finalist in the RESI Innovators Pitch Challenge.
Later that same day, Mr. Koller will also be speaking at NEXUS 2025 from 3 p.m. to 9 p.m. at the Hanger in South San Francisco. During these presentations, he will provide an overview of Alphyn's corporate developments and discuss their lead product candidate, Zabalafin Hydrogel.
More on The Californer
- Top 10 AI Trading Agents Hit 75% Annual Return for Retail Traders (BP, CNQ, EQNR, WMB, VLO, MPC, OXY)
- Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
- Flow Opens Its Judgment Layer to Every Company Deploying AI Agents
- Mountzo Launches TV Mounting in Sacramento, Expanding Nationwide
- Thursday's Hair Solutions Announces Online Booking Option to Schedule Free Consultations
Zabalafin Hydrogel is currently in development to treat atopic dermatitis (AD), a chronic skin condition that affects millions of people worldwide. It is set to begin Phase 2b clinical trials this year and has shown promising results in treating all aspects of AD - including bacterial causes and exacerbation of the disease, as well as managing symptoms such as itchiness, inflammation, and infection.
Alphyn's second candidate is aimed at treating epidermolysis bullosa, a group of rare and potentially fatal skin diseases. With these innovative Multi-Target Therapeutics®, Alphyn hopes to make significant advancements in the field of dermatology and improve the quality of life for those suffering from these conditions.
Investors and industry professionals alike are eagerly anticipating Mr. Koller's presentations and updates on Alphyn's groundbreaking clinical programs during J.P Morgan Healthcare Week next week in San Francisco.
Filed Under: Business
0 Comments
Latest on The Californer
- California's nation-leading AI framework just got stronger, Governor Newsom signs more first-in-the-nation worker protections and more
- California: Governor Newsom proclaims a Day of Remembrance for Indian Boarding Schools
- California: Governor Newsom signs bill to ban child marriage
- California: Governor Newsom signs bill strengthening local journalism, defending a free press as cornerstone of democracy
- Long Beach: Community Invited to Attend No-Cost Waste Reduction & Recycling Workshops in English and Spanish from October 2026 through August 2027
- Rabies-Positive Bat Confirmed in Long Beach
- City of Long Beach Issues Extreme Heat Alert, Advises Residents to Take Precautions Against Heat
- Fiscal Year 2027 Begins; City of Long Beach Provides Update on Efforts to Address Staffing Impacts
- City of Long Beach Awards $205,000 to Level Up Small Businesses
- Long Beach: Community Invited to Celebrate Reopening of the Newly Renovated Drake Park Community Center
- Los Angeles County Will Begin Mailing Vote by Mail Ballots to Registered Voters in the City of Long Beach Beginning Oct. 1, 2026
- City of Long Beach Launches Third Cohort of the Urban Planning and Design Internship Program
- Long Beach Public Library Announces 2027 Youth Poet Laureate Program
- Build a Distinctive Brand Identity That Connects With Customers
- MVP Advances Semiconductor Inspection with AOI, Metrology & AI at SEMICON West 2026
- Great Awakening Report Continues Independent Research on Truth, Awakening, and Disclosure
- Community Colleges of Ventura County to Host State of the District Event
- Ventura College to Host Cash for College Workshops in October
- PQCrypto Welcomes Technology Executive John Basmadjian to Board of Directors
- GIC Car Clinic Joins Brakes for Breasts With Free Brake Checks and Free Pad